Skip to main content
XLO logo

XLO · Xilio Therapeutics, Inc.

Track XLO — free
$9.23 +0.00 (+0.00%) At close · Aug 21
Market Cap
$53.37M
Shares
5.78M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

Short Squeeze Score
73/100
Short interest 7.4% of shares — P83 Days to cover 12.3 — P92 Price vs VWAP +3.9% — P64 Short-volume trend -11.1% — P16 Short interest change +58.8% — P92 Worst FTD 0.13% of shares — P86

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-07-31). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-08-31 Scheduled
FINRA publishes Sep 10
2026-08-14 Scheduled
FINRA publishes Aug 25
2026-07-31 425,882 268,180 +157,702 12.28
2026-07-15 268,180 174,619 +93,561 4.52
2026-06-30 174,619 173,470 +1,149 3.65
2026-06-15 173,470 165,274 +8,196 7.09
2026-05-29 165,274 171,370 -6,096 5.43
2026-05-15 171,370 162,958 +8,412 1.80
2026-04-30 162,958 174,319 -11,361 4.94
2026-04-15 174,319 182,492 -8,173 5.92
2026-03-31 182,492 2,231,716 -2,049,224 3.13
2026-03-13 159,408 150,982 +8,426 4.64
2026-02-27 150,982 153,969 -2,987 6.77
2026-02-13 153,969 152,814 +1,154 3.58
2026-01-30 152,814 149,203 +3,611 4.14
2026-01-15 149,203 154,901 -5,697 5.83
2025-12-31 154,901 220,598 -65,697 8.04
2025-12-15 220,598 476,844 -256,247 4.19
2025-11-28 476,844 493,799 -16,954 17.93
2025-11-14 493,799 439,736 +54,062 5.92
2025-10-31 439,736 375,113 +64,623 8.58
2025-10-15 375,113 368,740 +6,374 12.42
2025-09-30 368,740 351,697 +17,042 13.34
2025-09-15 351,697 307,197 +44,500 3.37
2025-08-29 307,197 307,769 -572 10.85
Showing 1–23 of 23 settlements
Key facts CIK 1840233 CUSIP 98422T209 13F (30d) 26 filings 26 filers Visit website Investor relations